Monday, January 29, 2024 5:35:10 PM
Dr. Mears is a recognized pioneer and leading expert in nano-scale material science and engineering. In the mid-1980’s, Dr. Mears re-engineered silica optical fiber by adding atoms of erbium (rare earth element) to silica to invent the Erbium Doped Fiber Amplifier (EDFA), a transformative technology for long-distance optical networks.
.
In optical telecommunications this happened between the mid-1980s and 1990s when a device called the erbium-doped fibre amplifier was born, grew up and went to work. It revolutionized telecommunications and is nowadays a vital part of the global optical fibre network that is the backbone of the information age.
.
Patince folks as the MST play out is a long term big payday.
.
Took a few years but Atomera's is now sitting in the right spot at the right time.
2022 -Nvidia CEO Jensen Huang Our transistors are going to find limits, and we’re at atomic scales. And so [this problem] is a place where material science is really going to come in handy.”
.
MST being a material science a lot of companies are now have a more serious interest in.
Recent ATOM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:02:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/11/2024 08:01:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/08/2024 09:02:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/08/2024 09:01:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:19 AM
- Media Alert: Atomera to Present Joint Paper with Soitec and San Jose State University on Advanced RF Technologies at 8th IEEE Electronic Devices Technology and Manufacturing (EDTM) Conference 2024 • Business Wire • 02/22/2024 10:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 09:47:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 03:59:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:40:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:30:33 PM
- Atomera’s Advanced Materials R&D Provides Specialized Expertise to the CHIPS and Science Act Funded Innovation Hub • Business Wire • 10/17/2023 09:00:00 PM
- Media Alert: Atomera to Present at SISPAD 2023 • Business Wire • 09/20/2023 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 08:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:35:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:35:22 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM